SEC Form 4 · accession 0001628280-26-061940
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert M Plenge
Director
Period of report
Sep 10, 2026
Accepted (ET)
Sep 14, 2026 · 6:55 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 10, 2026 | A | 6,140 | $0.00 | A | 6,140 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock units granted on September 10, 2026. Price not applicable.